Document is current
Any future updates will be listed below
-
Authors
Qiu, Xintao https://orcid.org/0000-0002-8560-7017
Boufaied, Nadia
Hallal, Tarek
Feit, Avery https://orcid.org/0000-0002-6586-9052
de Polo, Anna
Luoma, Adrienne M. https://orcid.org/0000-0001-9504-2403
Alahmadi, Walaa
Larocque, Janie
Zadra, Giorgia
Xie, Yingtian
Gu, Shengqing
Tang, Qin
Zhang, Yi https://orcid.org/0000-0002-7453-6188
Syamala, Sudeepa https://orcid.org/0000-0003-0476-3083
Seo, Ji-Heui
Bell, Connor
O’Connor, Edward
Liu, Yang
Schaeffer, Edward M. https://orcid.org/0000-0003-0699-1899
Jeffrey Karnes, R.
Weinmann, Sheila
Davicioni, Elai
Morrissey, Colm
Cejas, Paloma https://orcid.org/0000-0002-2090-7748
Ellis, Leigh https://orcid.org/0000-0003-4739-5049
Loda, Massimo https://orcid.org/0000-0001-9674-8379
Wucherpfennig, Kai W. https://orcid.org/0000-0002-1829-302X
Pomerantz, Mark M.
Spratt, Daniel E. https://orcid.org/0000-0002-5973-4741
Corey, Eva https://orcid.org/0000-0002-9244-3807
Freedman, Matthew L.
Shirley Liu, X. https://orcid.org/0000-0003-4736-7339
Brown, Myles https://orcid.org/0000-0002-8213-1658
Long, Henry W. https://orcid.org/0000-0001-6849-6629
Labbé, David P. https://orcid.org/0000-0001-8864-8765
- License Information
-
More Information
Article History
Received: 13 April 2021
Accepted: 22 April 2022
First Online: 13 May 2022
Competing interests
: R.J.K. receive royalties from GenomeDx (now Veracyte) for Decipher testing. S.W. receives research funding from PreludeDX. K.W.W. serves on the scientific advisory board of T-Scan Therapeutics, SQZ Biotech, Nextechinvest and receives sponsored research funding from Novartis. He is a co-founder of Immunitas, a biotech company. These activities are not related to the research reported in this publication. D.E.S. receives personal fees from Janssen, AstraZeneca, and Blue Earth and funding from Janssen. E.C. received research funding under institutional SRA from Janssen Research and Development, Bayer Pharmaceuticals, KronosBio, Forma Pharmaceutics, Foghorn, Gilead, Sanofi, AbbVie, MacroGenics, and GSK. M.L.F. reports other support from Nuscan Diagnostics outside the submitted work. X.S.L. conducted the work while being a faculty at the Dana-Farber Cancer Institute and is currently a board member and CEO of GV20. M.B. and H.W.L. receives sponsored research support from Novartis. M.B. is a consultant to Aleta Biotherapeutics and H3 Biomedicine and serves on the SAB of Kronos Bio. The remaining authors declare no competing interests.
